Treatment with a catalytic antioxidant corrects the neurobehavioral defect in ataxia-telangiectasia mice.

Browne SE, Roberts LJ, Dennery PA, Doctrow SR, Beal MF, Barlow C, Levine RL
Free Radic Biol Med. 2004 36 (7): 938-42

PMID: 15019978 · DOI:10.1016/j.freeradbiomed.2004.01.003

Ataxia-telangiectasia is caused by mutations in the ATM gene, the protein product of which is essential for effective response to double-stranded DNA breaks. Loss of ATM function explains most aspects of the disease, but not the cerebellar neurodegeneration characteristic of the disease. Mice lacking ATM provide an excellent model of the human disorder. In addition to deficient response to DNA damage, these mice exhibit oxidative stress, which we hypothesized is the cause of cerebellar dysfunction. We show that treatment with a catalytic antioxidant corrects the neurobehavioral deficit in these mice.

MeSH Terms (18)

Animals Antioxidants Ataxia Telangiectasia Ataxia Telangiectasia Mutated Proteins Brain Catalysis Cell Cycle Proteins Disease Models, Animal DNA-Binding Proteins Fatty Acids Mice Mice, Knockout Organometallic Compounds Oxidation-Reduction Protein-Serine-Threonine Kinases Rotarod Performance Test Salicylates Tumor Suppressor Proteins

Connections (1)

This publication is referenced by other Labnodes entities: